Izumi Komoto
Overview
Explore the profile of Izumi Komoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
1040
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Takai G, Hanaoka K, Nagano K, Okada T, Honda M, Komoto I
Ann Nucl Med
. 2024 Jul;
38(11):927-932.
PMID: 39060833
Objective: When patients administered Lu-DOTATATE are released or discharged from rooms where radiopharmaceuticals are used, the time required for release or discharge varies across patients. This study investigated whether the...
2.
Kinugasa M, Inui A, Satsuma S, Kobayashi D, Sakata R, Morishita M, et al.
J Pediatr Orthop
. 2023 May;
43(7):e538-e544.
PMID: 37193656
Background: A timely diagnosis of developmental dysplasia of the hip (DDH) is important for satisfactory clinical outcomes. Ultrasonography is a useful tool for DDH screening; however, it is technically demanding....
3.
Imamura M, Komoto I, Taki Y
Surg Today
. 2022 Dec;
53(12):1325-1334.
PMID: 36473964
In patients with multiple endocrine neoplasia type 1 syndrome (MEN 1) and Zollinger-Ellison syndrome (ZES), gastrinomas arise from the duodenum, about 60% are multiple, and about 15% of patients have...
4.
Komoto I, Kokudo N, Aoki T, Morizane C, Ito T, Hashimoto T, et al.
Jpn J Clin Oncol
. 2022 Apr;
52(7):716-724.
PMID: 35411926
Background: This phase I/II study was conducted to evaluate the efficacy, safety and pharmacokinetics of streptozocin (STZ) in Japanese patients with unresectable or metastatic gastroenteropancreatic neuroendocrine tumors. Methods: Twenty-two patients...
5.
Masui T, Ito T, Komoto I, Kojima S, Kasai Y, Tanabe M, et al.
Int J Clin Oncol
. 2022 Feb;
27(5):840-849.
PMID: 35178624
Background: Neuroendocrine neoplasm (NEN) is a comparatively rare tumor that has been considered indolent. Due to these characteristics, detailed epidemiological data have not been analyzed in Japan. To elucidate the...
6.
Watanabe H, Fujishima F, Komoto I, Imamura M, Hijioka S, Hara K, et al.
Cancers (Basel)
. 2022 Feb;
14(3).
PMID: 35159042
Somatostatin analogues (SSAs) are widely used to treat gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Somatostatin receptor 2 (SSTR2) immunoreactivity serves as a predictive marker of the therapeutic efficacy of SSAs in pancreatic...
7.
Takeoka Y, Kakutani K, Miyamoto H, Suzuki T, Yurube T, Komoto I, et al.
Neurospine
. 2022 Jan;
18(4):778-785.
PMID: 35000332
Objective: To clarify the complications of posterior fusion for atlantoaxial instability (AAI) in children with Down syndrome and to discuss the significance of surgical intervention. Methods: Twenty pediatric patients with...
8.
Ito T, Masui T, Komoto I, Doi R, Osamura R, Sakurai A, et al.
J Gastroenterol
. 2021 Sep;
56(11):1033-1044.
PMID: 34586495
Neuroendocrine neoplasms (NENs) are rare neoplasms that occur in various organs and present with diverse clinical manifestations. Pathological classification is important in the diagnosis of NENs. Treatment strategies must be...
9.
Aoki T, Kubota K, Kiritani S, Arita J, Morizane C, Masui T, et al.
J Hepatobiliary Pancreat Sci
. 2021 Apr;
28(6):489-497.
PMID: 33792204
Background/purpose: Hepatic resection is considered the treatment of choice for neuroendocrine liver metastases (NELM). However, the safety and efficacy of resection have not been fully evaluated using a large cohort....
10.
Masui T, Ito T, Komoto I, Uemoto S
BMC Cancer
. 2020 Nov;
20(1):1104.
PMID: 33189127
Background: The worldwide prevalence and incidence of neuroendocrine neoplasms (NEN) have been increasing recently, although few studies have analyzed data on the current situation of NENs in Japan. Here, the...